Vineti.JPG
Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
March 24, 2021 07:00 ET | Vineti
Genentech, Takeda, Adaptimmune and other industry leaders join Vineti to form the core of this strategic collaboration. The group is focused on working industry-wide to promote new and updated...
22157.jpg
Global T-Cell Therapies Market Report 2021: Type of Therapy, Target Indications, Target Antigens, Key Players and Key Regions 2020-2030
February 19, 2021 04:33 ET | Research and Markets
Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "Global T-Cell Therapies Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key Players and Key Regions: Industry Trends and...
22157.jpg
T-Cell Immunotherapy Market Report 2021 - Global Forecast to 2025: Opportunities of Commercialisation and Funding by Pharmaceutical Companies
February 15, 2021 05:28 ET | Research and Markets
Dublin, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Research Report by Mechanism Of Action, by Type of Therapy, by Indication - Global Forecast to 2025 - Cumulative Impact of...
22157.jpg
Global Apoptosis Assays Market Report 2020: Apoptosis Assay Kits Lead the Demand with 42.5% Share - Forecast to 2026
February 01, 2021 04:08 ET | Research and Markets
Dublin, Feb. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Apoptosis Assays Market - Products, Detection Technologies, Applications and End-Use Markets" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global CAR-T Therapy Market Opportunities and Strategies Report 2020: COVID-19 Impact and Recovery - Forecast to 2030
January 28, 2021 09:03 ET | Research and Markets
Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "CAR-T Therapy Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...
22157.jpg
Outlook on the CAR-T Cell Therapy Global Market to 2027 - Capitalize on Emerging Trends
January 05, 2021 06:33 ET | Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials and Trends, 2021" report has been added to ResearchAndMarkets.com's offering. ...
Harpoon_logo (002).jpg
Harpoon Therapeutics Doses First Patient with HPN328, an Anti-DLL3 T Cell Engager for Treatment of Small Cell Lung Cancer and other DLL3-Associated Tumors
January 04, 2021 07:30 ET | Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today...
22157.jpg
Global CAR T-cell Therapy Market Trajectory & Analytics Report 2020-2027 Featuring bluebird bio, CARsgen Therapeutics, Celgene Corp, Gilead Sciences, & Novartis
December 30, 2020 07:33 ET | Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global CAR T-cell Therapy...
22157.jpg
Global CAR-T Pipeline Insight Report 2020: Overview, Landscape, Therapeutic Assessment, Current Treatment Scenario and Emerging Therapies
December 30, 2020 04:38 ET | Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "CAR-T - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. The "CAR-T - Pipeline Insight, 2020," report...
22157.jpg
Global Checkpoint Inhibitors Market Report 2020-2030: COVID-19 Growth and Changes
December 22, 2020 05:23 ET | Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. ...